Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Express Scripts
US Department of Justice
Argus Health
QuintilesIMS
Deloitte
Boehringer Ingelheim
Baxter
Healthtrust
Citi

Generated: January 19, 2018

DrugPatentWatch Database Preview

Betamethasone dipropionate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for betamethasone dipropionate and what is the scope of betamethasone dipropionate patent protection?

Betamethasone dipropionate
is the generic ingredient in eleven branded drugs marketed by Fougera Pharms, Glenmark Generics, Perrigo New York, Taro, Tolmar, Schering, Merck Sharp Dohme, Savage Labs, Actavis Mid Atlantic, Pharmaderm, Teva, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, Teligent Pharma Inc, Promius Pharma Llc, Leo Pharma As, Perrigo Israel, and Glenmark Pharms, and is included in sixty-one NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Betamethasone dipropionate has six patent family members in four countries.

There are sixty-six drug master file entries for betamethasone dipropionate. Twenty-one suppliers are listed for this compound.
Summary for betamethasone dipropionate
Pharmacology for betamethasone dipropionate

US Patents and Regulatory Information for betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme LOTRISONE betamethasone dipropionate; clotrimazole LOTION;TOPICAL 020010-001 Dec 8, 2000 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Israel CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 200174-001 Dec 12, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION, AUGMENTED;TOPICAL 077111-001 May 21, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering DIPROSONE betamethasone dipropionate LOTION;TOPICAL 017781-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 070281-001 Jul 31, 1985 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 071012-001 Feb 3, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmaderm BETAMETHASONE DIPROPIONATE betamethasone dipropionate CREAM;TOPICAL 019136-001 Jun 26, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro BETAMETHASONE DIPROPIONATE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 076543-001 Dec 9, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Pharms CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE betamethasone dipropionate; clotrimazole CREAM;TOPICAL 202894-001 Oct 30, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 071477-001 Aug 10, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme DIPROLENE betamethasone dipropionate LOTION, AUGMENTED;TOPICAL 019716-001 Aug 1, 1988 ➤ Subscribe ➤ Subscribe
Schering DIPROLENE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019408-001 Jan 31, 1986 ➤ Subscribe ➤ Subscribe
Schering DIPROLENE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019408-001 Jan 31, 1986 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741-001 Jul 27, 1983 ➤ Subscribe ➤ Subscribe
Schering DIPROLENE betamethasone dipropionate GEL, AUGMENTED;TOPICAL 019408-002 Nov 22, 1991 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme DIPROLENE AF betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019555-001 Apr 27, 1987 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Novartis
Citi
Cipla
Healthtrust
Baxter
Deloitte
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot